Surrounding Boulevard has not too long ago up to date its holdings in Agenus Holdings, Inc. (NASDAQ: AGEN) to one,937,739 stocks. This general represents an building up of one,632,739 stocks from the former submitting for the quarter ended March 31, 2021. Agenus Holdings is a biotechnology corporate that develops immunotherapies and vaccines to regard most cancers and infectious illnesses. The corporate’s merchandise come with Prophage Layout vaccine, an off-the-shelf healing vaccine for glioblastoma, and its manage product candidate, Balstilimab, is an anti-PD-1 checkpoint inhibitor. Surrounding Boulevard’s holdings in Agenus Holdings constitute 3.2% of the corporate’s general remarkable stocks.
Don’t miss interesting posts on Famousbio
